Stocks · Healthcare · Biotechnology
Editas Medicine, Inc. EDIT
$2.62 +3.97% Close, Oct 2, 2026 · NASDAQ · Market cap $402.1M
Strong growthHigh risk
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -174.7% from -616.9% a year earlier.
- The diluted share count rose 41.3% in a year.
- Earnings beat analyst estimates in each of the last 4 quarters (average surprise over the last four: +40.5%).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 32%
- Revenue growth, 3-year CAGRTop 24%
- Revenue growth accelerationTop 11%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 28%
- Gross marginBottom 42%
- Operating marginBottom 26%
- Accruals (lower is better)Bottom 5%
- Interest coverBottom 18%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 25%
- Free-cash-flow yieldBottom 16%
- EBITDA / enterprise valueBottom 22%
- Sales / enterprise valueBottom 47%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 28%
- 6-month returnBottom 41%
- 1-year return vs S&P 500Bottom 25%
- Distance from 52-week highBottom 38%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 15%
- Consecutive EPS beatsTop 19%
- Share of analysts rating BuyBottom 23%
- Upside to consensus price targetTop 46%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 31%
- Maximum drawdown, 3 yearsBottom 13%
- Beta vs S&P 500 (lower is better)Bottom 5%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 8.0% | 20.8% | ↑ |
| Gross margin | -139.0% | 56.9% | ↑ |
| Operating margin | -616.9% | -174.7% | ↑ |
| FCF margin | -526.8% | -256.5% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 20.8% | 8.0% | ↑ | Top 32% |
| Gross margin | 56.9% | -139.0% | ↑ | Bottom 42% |
| Operating margin | -174.7% | -616.9% | ↑ | Bottom 26% |
| Net margin | -157.3% | -608.9% | ↑ | — |
| Free-cash-flow margin | -256.5% | -526.8% | ↑ | — |
| Return on invested capital | -46.8% | — | Bottom 28% | |
| Revenue growth, 3-year CAGR | 27.1% | — | Top 24% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 19.3%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 18.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +342.6 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -39.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -37.81%
- Shareholder yield
- -37.81%
- Share count change, 1 year
- +41.3%
- Share count change, 3-year CAGR
- +18.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 4
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +40.5%
- Average 2-day reaction, last 8
- +5.5%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $4.50
- Target vs current price
- +71.8%
- Analysts with a rating
- 26
- Share rating Buy or Strong Buy
- 58%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +44.5% | -0.7% | +6.5% | +10.8% | — |
| May 5, 2026 | +13.3% | +1.3% | +2.0% | -6.0% | -10.3% |
| Mar 9, 2026 | +77.8% | +16.0% | +22.0% | +36.0% | +41.0% |
| Nov 10, 2025 | +26.3% | +2.0% | +5.3% | -2.0% | -32.4% |
| Aug 12, 2025 | -53.7% | +4.1% | +24.1% | +25.5% | +26.4% |
| May 12, 2025 | -63.1% | +6.2% | +4.1% | +33.1% | +74.5% |
| Mar 5, 2025 | -41.0% | +16.5% | -16.5% | -35.8% | +4.0% |
| Nov 4, 2024 | +1.3% | -1.0% | +7.2% | -24.7% | -55.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.15 | -$0.27 | +44.5% | $11.9M |
| May 5, 2026 | -$0.26 | -$0.30 | +13.3% | $2.8M |
| Mar 9, 2026 | -$0.06 | -$0.27 | +77.8% | $24.7M |
| Nov 10, 2025 | -$0.28 | -$0.38 | +26.3% | $7.5M |
| Aug 12, 2025 | -$0.63 | -$0.41 | -53.7% | $3.6M |
| May 12, 2025 | -$0.92 | -$0.56 | -63.1% | $4.7M |
| Mar 5, 2025 | -$0.55 | -$0.39 | -41.0% | $30.6M |
| Nov 4, 2024 | -$0.75 | -$0.76 | +1.3% | $61,000 |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 5.02× | — | — | Bottom 47% |
| Free-cash-flow yield | -29.98% | — | — | Bottom 16% |
| Earnings yield | -28.54% | — | — | Bottom 25% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -5.7%
- 200-day average slope (20 days)
- +1.1%
- Distance from 50-day average
- -7.5%
- Distance from 200-day average
- -0.7%
- RSI (14)
- 44.6
- Relative volume
- 0.70×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 67.3%
- Volatility vs own 5-year history
- 13th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.55
- Correlation with S&P 500
- 0.42
- Current drawdown from 1-year high
- -36.9%
- Maximum drawdown, 3 years
- -91.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 8, 2021 | Apr 8, 2025 | -98.9% | 1066 days | Not yet recovered |
| Oct 16, 2020 | Nov 18, 2020 | -17.7% | 23 days | 11 days (Dec 4, 2020) |
| Dec 28, 2020 | Dec 31, 2020 | -16.9% | 3 days | 4 days (Jan 7, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $402.1M
- EPS, diluted (TTM)
- -$0.75
- Revenue (TTM)
- $47.0M
- 52-week range
- $1.66 – $4.54
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $25.5M | $19.7M | $78.1M | $32.3M | $40.5M |
| Gross profit | $20.5M | $13.4M | $72.1M | -$166.9M | $40.5M |
| Operating income | -$193.1M | -$225.9M | -$169.2M | -$251.2M | -$99.3M |
| Net income | -$192.5M | -$220.4M | -$153.2M | -$237.1M | -$160.1M |
| EPS (diluted) | -$2.85 | -$3.21 | -$2.02 | -$2.88 | -$1.80 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $61,000 | $30.6M | $4.7M | $3.6M | $7.5M | $24.7M | $2.8M | $11.9M |
| Net income | -$62.1M | -$45.4M | -$76.1M | -$53.2M | -$25.1M | -$5.6M | -$25.0M | -$18.2M |
| EPS (diluted) | -$0.75 | -$0.55 | -$0.92 | -$0.63 | -$0.28 | -$0.06 | -$0.26 | -$0.15 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$163.8M | -$177.3M | -$132.2M | -$210.3M | -$165.2M |
| Capital expenditure | -$8.0M | -$4.1M | -$4.7M | -$8.8M | -$607,000 |
| Free cash flow | -$171.8M | -$181.5M | -$136.9M | -$219.1M | -$165.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $249.5M | $1.3M | $117.1M | $56.0M | $43.3M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $211.6M
- Total assets
- $237.4M
- Total liabilities
- $132.1M
- Total debt
- $15.5M
- Net debt
- -$166.3M
- Shareholders’ equity
- $105.3M
As of Jun 30, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 29,964,193
- Days to cover
- 15.72
- Change vs previous report
- -0.9%
FINRA short interest, settlement date Sep 15, 2026.